Insufficient scRNA-seq data for expression of ASB12 at single-cell level.
Insufficient scRNA-seq data for expression of ASB12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 99% | 39.51 | 178 / 180 | 56% | 1.12 | 240 / 430 |
| adrenal gland | 87% | 18.19 | 225 / 258 | 62% | 1.29 | 143 / 230 |
| intestine | 89% | 23.40 | 861 / 966 | 36% | 0.66 | 189 / 527 |
| uterus | 93% | 23.45 | 158 / 170 | 31% | 0.97 | 144 / 459 |
| bladder | 90% | 36.14 | 19 / 21 | 24% | 0.45 | 123 / 504 |
| kidney | 90% | 18.66 | 80 / 89 | 21% | 0.30 | 192 / 901 |
| prostate | 96% | 31.09 | 234 / 245 | 11% | 0.17 | 55 / 502 |
| thymus | 81% | 15.06 | 526 / 653 | 26% | 0.36 | 155 / 605 |
| stomach | 76% | 14.64 | 274 / 359 | 28% | 0.49 | 81 / 286 |
| muscle | 100% | 1858.36 | 803 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 41.96 | 1305 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 83% | 16.68 | 1206 / 1445 | 14% | 0.28 | 25 / 183 |
| breast | 87% | 19.42 | 401 / 459 | 8% | 0.14 | 94 / 1118 |
| heart | 93% | 78.94 | 800 / 861 | 0% | 0 | 0 / 0 |
| lung | 76% | 13.82 | 440 / 578 | 11% | 0.17 | 124 / 1155 |
| spleen | 84% | 15.98 | 202 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 48% | 6.06 | 159 / 328 | 28% | 0.45 | 50 / 178 |
| adipose | 71% | 13.17 | 854 / 1204 | 0% | 0 | 0 / 0 |
| brain | 59% | 8.87 | 1564 / 2642 | 8% | 0.14 | 59 / 705 |
| skin | 61% | 12.86 | 1097 / 1809 | 7% | 0.11 | 32 / 472 |
| liver | 20% | 2.29 | 46 / 226 | 4% | 0.07 | 18 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.32 | 7 / 45 |
| peripheral blood | 14% | 3.39 | 132 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.15 | 3 / 29 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0000151 | Cellular component | ubiquitin ligase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ASB12 |
| Protein name | Ankyrin repeat and SOCS box protein 12 (ASB-12) |
| Synonyms | |
| Description | FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
| Accessions | Q8WXK4 ENST00000362002.3 [Q8WXK4-2] |